PROGRAMMABLE INFUSION PUMPS AND CATHETERS MARKET ANALYSIS

Programmable Infusion Pumps and Catheters Market, by Product Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Implantable Pumps, Patient Controlled Analgesia Pumps, and Pump Accessories), by Modality (Portable and Stationary), by Application (Oncology, Pediatrics/Neonatology, Pain, Gastroenterology, Hematology, and Diabetes), by Channel Type (Single Channel and Multi-Channel), by End User (Hospitals, Ambulatory Clinics, Homecare, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Published In : Apr 2019
Code : CMI2565
Pages :181
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Company strategies such as acquiring funding for research and product launches, are expected to have a positive impact on global programmable infusion pumps and catheters market growth.

Key players are involved in research and development of new products, which is expected to aid in growth of the market. For instance, in March 2017, Ivenix, Inc., a medical technology company involved in development of next generation infusion systems, raised US$ 50 million.

Some of the major players operating in the global programmable infusion pumps and catheters market include, ICU Medical, Inc., Smiths Group plc., Baxter International Inc., Fresenius Se & Co. KGaA, Johnson & Johnson, Medtronic plc., Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, and Moog Inc.